Luísa Zuravski

Dr. Luísa Zuravski


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Brazilian Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
CGCamila Martins Güez
Camila Martins Güez
RSRaul Oliveira De Souza
Raul Oliveira De Souza
PFPaula Fischer
Paula Fischer
MLMaria Fernanda De Moura Leão
Maria Fernanda De Moura Leão
JDJonathaline Apollo Duarte
Jonathaline Apollo Duarte
MMMichel Mansur Machado
Michel Mansur Machado
Ocimum is one of the most important genera of the Lamiaceae family. Several studies about basil and its popular use reveal many characteristics of the herb, including its use as antioxidant, anti-aging, anti-inflammatory, anti-carcinogenic, anti-microbial, and cardiovascular agents, among others. In this paper, we evaluated genotoxic, oxidative, and anti-inflammatory parameters from the extract of Ocimum basilicum in different concentrations, using human leukocytes cultures exposed to challenging agents. Our results confirm that the O. basilicum extract acts as an antioxidant and effectively reverts or subjugates the effects of high oxidizing agents such as hydrogen peroxide. These actions are attributed to its composition, which is rich in polyphenols and flavonoids as well as compounds such as rosmarinic acid, all of which have well-known antioxidant activity. We also show that our basil extract presents anti-inflammatory properties, the mechanism of which is a composed interaction between the inhibition of pro-inflammatory mediator and the stimulation of anti-inflammatory cytokines. Although pharmacodynamics studies are necessary to evaluate the activities in vivo, our results demonstrated that basil could act as an antioxidant and anti-inflammatory and a possible alternative for medicinal treatment.

29 October 2018 in Toxicology Research
Verified
Journal Article
Open access
PDF file
JFJassana Moreira Floriano
Jassana Moreira Floriano
EREmanoeli da Rosa
Emanoeli da Rosa
QAQueila Daiane Fonseca Do Amaral
Queila Daiane Fonseca Do Amaral
LZLuísa Zuravski
Luísa Zuravski
PCPamella Eduardha Espindola Chaves
Pamella Eduardha Espindola Chaves
LOLuís Flávio Souza de Oliveira
Luís Flávio Souza de Oliveira
The use of food colorings has a long-recorded history.

2 February 2016 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
PDF file
MMMichel Mansur Machado
Michel Mansur Machado
LOLuis F.S. de Oliveira
Luis F.S. de Oliveira
LZLuísa Zuravski
Luísa Zuravski
RSRaul O. de Souza
Raul O. de Souza
PFPaula Fischer
Paula Fischer
MAMargareth L. Athayde
Margareth L. Athayde
Euphorbia tirucalli (L.), commonly known as aveloz, has been indiscriminately used in popular medicine to treat various illnesses. However, some components can have devastating consequences. Injury to a cell's genetic material can cause mutations, cancer, and cell death. Our main goal in this work was to evaluate the genotoxic and cytotoxic effects of E. tirucalli extract on human leukocytes. For this purpose, we performed a phytochemical analysis to evaluate the plant's components. In the second step, we treated cultured human leukocytes with different concentrations of the dry extract of the plant and then evaluated the oxidative and genotoxic profiles of these leukocytes. We found that at 1% and 10% concentrations, the aveloz extract acted as a genotoxic agent that could damage DNA and increase oxidative damage. We conclude that despite its popular use, aveloz can act as a genotoxic agent, especially when it contains phorbol ester. Aveloz's indiscriminate use might actually promote tumors and therefore carry a considerable genetic risk for its users.

1 September 2014 in Journal of Functional Foods
Verified
Journal Article
Closed access
BPBruna Cocco Pilar
Bruna Cocco Pilar
AGAngélica Aparecida da Costa Güllich
Angélica Aparecida da Costa Güllich
DSDeise Jaqueline Ströher
Deise Jaqueline Ströher
LZLuísa Zuravski
Luísa Zuravski
JMJuliana Mezzomo
Juliana Mezzomo
VMVanusa Manfredini
Vanusa Manfredini

1 January 2014 in World Journal of Experimental Medicine
Verified
Journal Article
Open access
MFMarília Sabo Fernandes
Marília Sabo Fernandes
TRTatiana Tamborena Rissi
Tatiana Tamborena Rissi
LZLuísa Zuravski
Luísa Zuravski
JMJuliana Mezzomo
Juliana Mezzomo
CVCarmen Regla Vargas
Carmen Regla Vargas
RPRobson Luiz Puntel
Robson Luiz Puntel
To determine the plasmatic iron content and evaluate the oxidative stress (OS) markers in subjects receiving blood therapy. Thirty-nine individuals with unspecified anemia receiving blood transfusions and 15 healthy subjects were included in the study. Anemic subjects were divided into three subgrouP: (1) those that received up to five blood transfusions (n = 14); (2) those that received from five to ten transfusions (n = 11); and (3) those that received more than ten transfusions (n = 14). Blood samples were collected by venous arm puncture and stored in tubes containing heparin. The plasma and cells were separated by centrifugation and subsequently used for analyses. Statistical analyses were performed using Kruskal-Wallis analysis of variance followed by Dunn's multiple comparison tests when appropriate. The eletrophoretic hemoglobin profiles of the subjects included in this study indicated that no patients presented with hemoglobinopathy. Labile plasmatic iron, ferritin, protein carbonyl, thiobarbituric acid-reactive substances (TBARS) and dichlorofluorescein diacetate oxidation were significantly higher (P < 0.05), whereas total thiol levels were significantly lower (P < 0.05) in transfused subjects compared to controls. Additionally, the activity of catalase, superoxide dismutase and glutathione peroxidase were significantly lower in the transfused subjects (P < 0.05). Antioxidant enzyme activities and total thiol levels were positively correlated (P < 0.05), and negatively correlated with the levels of protein carbonyl and TBARS (P < 0.05). In contrast, protein carbonyl and TBARS were positively correlated (P < 0.05). Altogether, these data confirm the involvement of OS in patients following therapy with repeated blood transfusions. Our data reveal that changes in OS markers are correlated with levels of labile plasmatic iron and ferritin and the number of transfusions.

1 November 2017 in Journal of Functional Foods
Verified
Journal Article
Closed access
EREmanoeli da Rosa
Emanoeli da Rosa
QAQueila Daiane Fonseca Do Amaral
Queila Daiane Fonseca Do Amaral
JDJonathaline Apollo Duarte
Jonathaline Apollo Duarte
JLJéssica Tamara Limberger
Jéssica Tamara Limberger
PCPamella Eduardha Espindola Chaves
Pamella Eduardha Espindola Chaves
MMMichel Mansur Machado
Michel Mansur Machado